The Prevalence and Risks of Inappropriate Combination of Aspirin and Warfarin in Clinical Practice: Results From WARFARIN-TR Study
Ali Nazmi ÇalıkAhmet ÇelikElif ÇekirdekçiServet AltayDeniz ElçikMehmet Kadri AkboğaMine DurukanÇağrı YaylaMehdi ZoghiPublished in: Balkan medical journal (2018)
Our study demonstrated that 20.0% of patients taking warfarin use concomitant aspirin inappropriately in daily practice. Patients receiving aspirin with warfarin were demonstrated to have more comorbidities, lower time in therapeutic range levels, and higher bleeding rates.
Keyphrases
- atrial fibrillation
- low dose
- venous thromboembolism
- direct oral anticoagulants
- cardiovascular events
- end stage renal disease
- oral anticoagulants
- antiplatelet therapy
- ejection fraction
- chronic kidney disease
- primary care
- newly diagnosed
- risk factors
- physical activity
- cardiovascular disease
- prognostic factors
- climate change
- anti inflammatory drugs